Nora Henrikson, PhD, MPH

"I believe that our members are the key to helping us know how to deliver the best care possible."

Nora Henrikson, PhD, MPH

Associate Investigator, Kaiser Permanente Washington Health Research Institute
Associate Professor, Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science
Affiliate Associate Professor, University of Washington School of Public Health, Department of Health Systems and Population Health, and Institute for Public Health Genetics

Nora.B.Henrikson@kp.org

Curriculum vitae (CV)

Biography

Nora Henrikson (she/her) is an associate investigator at Kaiser Permanente Washington Health Research Institute. She leads a research portfolio focused on interventions to improve cancer care delivery, health equity, and patient outcomes.

Her current research explores methods for improving risk notification and cascading genetic testing for family members of people with hereditary cancers as well as interventions to mitigate cancer-related financial hardship. Dr. Henrikson also leads systematic evidence reviews on cancer screening and behavioral counseling with the Kaiser Permanente Evidence-based Practice Center.

Dr. Henrikson holds affiliate faculty appointments at the University of Washington School of Public Health in the Department of Health Systems and Population Health, and the Institute for Public Health Genetics. She is also an associate professor at the Bernard J. Tyson Kaiser Permanente School of Medicine.

She has a PhD from the University of Washington School of Public Health’s Institute for Public Health Genetics, an MPH from the University of North Carolina at Chapel Hill, and a BA (sociology) from Lehigh University.

RESEARCH INTERESTS AND EXPERIENCE

Cancer

Genetic testing for cancer risk, cancer-related financial hardship
Social Determinants of Health

Financial hardship, health equity
Health Services & Economics

Quantitative, qualitative, and mixed methods; intervention design; implementation science
Preventive Medicine
Evidence-Based Practice

Systematic review and evidence synthesis; epidemiology
Public Health Genetics

Social, ethical, and policy implications of genomics and precision health

Recent publications

Henrikson NB, Ellis WJ, Berry DL. "It's not like I can change my mind later": reversibility and decision timing in prostate cancer treatment decision-making. Patient Educ Couns. Nov;77(2):302-7. Epub 2009 Apr 21. PubMed

Henrikson NB, Bowen D, Burke W. Does genomic risk information motivate people to change their behavior? Genome Med. 2009 Apr 2;1(4):37. PubMed

James RD, Yu JH, Henrikson NB, Bowen DJ, Fullerton SM. Strategies and stakeholders: minority recruitment in cancer genetics research. Community Genet. 2008;11:241-49. PubMed

Henrikson NB, Harris JN, Bowen D. Predictors of recruitment method to a cancer genetics registry. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1387-92. PubMed

Henrikson NB, Burke W, Veenstra DL. Ancillary risk information and pharmacogenetic tests: social and policy implications. Pharmacogenomics J. 2008 Apr;8(2):85-9. PubMed

Battuello K, Henrikson NB. Access to and disclosure of genetic information: rights, duties and liabilities. In: Battuello K, Kuslzer P, O’Connor S, editors. Genetic technologies and the law: cases and materials. Carolina Academic Press; 2006. PubMed

Battuello K, Henrikson NB. Genetics and public health: past, present, and future In: Battuello K, Kuslzer P, O’Connor S, editors. Genetic technologies and the law: cases and materials. Carolina Academic Press; 2006. PubMed

Carlson JJ, Henrikson NB, Veenstra DL, Ramsey SD. Economic analyses of human genetics services: a systematic review. Genet Med. 2005 Oct;7(8):519-23. PubMed